From GlobeNewswire: 2025-02-24 09:31:00

The Global Biomarkers Market was valued at USD 67.92 billion in 2023 and is projected to reach USD 184.80 billion by 2032, with a CAGR of 11.78%. Key players include F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific Inc., and more. The market is driven by precision medicine, chronic diseases, and diagnostic technology advancements.

In 2023, the consumables segment led the market due to its role in clinical use and research. Safety biomarkers dominated in revenue, while efficacy biomarkers are expected to grow rapidly. Drug discovery & development was the leading application, with diagnostics set to expand. Cancer remained the dominant disease segment, while immunological diseases are projected to witness high growth. The demand for biomarkers is rising due to the increasing disease burden of rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. The market is segmented by product, type, application, and disease, with North America leading in 2023. Asia-Pacific is expected to be the growth leader, driven by increased healthcare expenditures and government support.

The Biomarkers Market Analysis & Outlook Report for 2024-2032 is available for purchase, offering insights into market dynamics, trends, and statistics. The report includes information on disease prevalence, biomarker testing adoption, healthcare spending, and regional analysis. Access the complete report details for a comprehensive understanding of the biomarkers market.

SNS Insider is a leading market research and consulting agency, providing clients with the knowledge needed to navigate changing market conditions. Through various techniques such as surveys and focus groups, we deliver current and accurate market data to help clients make informed decisions with confidence. Visit our website for more information on the biomarkers market analysis.



Read more at GlobeNewswire: Biomarkers Market Size to Hit USD 184.80 Billion by 2032,